
JC virus (JCV) is a causative agent of progressive multifocal leukoencephalopathy and belongs to Polyomavirus. In this article we describe our recent research relating to this virus. First, JCV's major capsid protein VP1 possesses a nuclear localization signal (NLS) and has the ability to construct a virus-like particle (VLP). We have investigated the mechanism of nuclear entry of JCV using VLP, and clarified the role of NLS. In vitro transport assay revealed that wild type VLP (wtVLP), but not deltaNLSVLP, entered the nuclei of cells. The nuclear transport of wtVLP was dependent on the addition of importins alpha and beta and was prevented by antibodies to nuclear pore complex (NPC). These results suggested that JCV VLP binds to cellular importins via the NLS of VP1 and is transported into the nucleus through the NPC. Second, a yeast two-hybrid screen of a human brain cDNA library demonstrated that the fasciculation and elongation protein zeta 1 (FEZ1) and the heterochromatin protein lalpha (HPla) are proteins that interacted with JCV agnoprotein (Agno). In vitro binding assay showed that Agno interacts directly with FEZ1 and HPlalpha. We have also shown that Agno induces the dissociation of FEZ1 from microtubules and dissociates the interaction between HPlalpha and lamin B receptor. We have demonstrated that interaction between Agno and these host proteins inhibited nuclear egress of JCV. Third, in order to inhibit JCV infection in infected cells, we synthesized siRNA which is specific for JCV Agno. Immunoblotting and immunocytochemical analysis demonstrated that expression levels of agnoprotein and VP1 were significantly inhibited by specific siRNA. In addition, levels of viral mRNAs and viral production were decreased in the cells transfected with Agno siRNA. Furthermore, viral production of cell treated with Agno siRNA was significantly inhibited. These results indicate that post-infection treatment with siRNAs, that targets JCV Agno suppresses virus production in JCV infected cells. Thus, siRNA directed against JCV encoding genes may provide a useful tool for suppression of JCV infection.
Cell Nucleus, Chromosomal Proteins, Non-Histone, Tumor Suppressor Proteins, Nuclear Localization Signals, Leukoencephalopathy, Progressive Multifocal, Nerve Tissue Proteins, Genetic Therapy, Karyopherins, JC Virus, Viroporin Proteins, DNA-Binding Proteins, Viral Proteins, Chromobox Protein Homolog 5, Antibodies, Antinuclear, Nuclear Pore, Humans, RNA, Viral, Capsid Proteins, Viral Regulatory and Accessory Proteins, RNA, Small Interfering, Adaptor Proteins, Signal Transducing
Cell Nucleus, Chromosomal Proteins, Non-Histone, Tumor Suppressor Proteins, Nuclear Localization Signals, Leukoencephalopathy, Progressive Multifocal, Nerve Tissue Proteins, Genetic Therapy, Karyopherins, JC Virus, Viroporin Proteins, DNA-Binding Proteins, Viral Proteins, Chromobox Protein Homolog 5, Antibodies, Antinuclear, Nuclear Pore, Humans, RNA, Viral, Capsid Proteins, Viral Regulatory and Accessory Proteins, RNA, Small Interfering, Adaptor Proteins, Signal Transducing
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
